BDX
VENTE TOTALE: 4 152 titres (~768 120,00 $ US)
- Insiders
- Polen Thomas E Jr
- Total bought
- —
- Total sold
- $768,120
- Last activity
- 2026-08-13
- Last synced
-
2026-08-21 23:36:53
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-08-16
The 0-100 score behind this signal and the full written analysis are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 45.4% | 45.2% | 42.2% | 44.9% | 45.1% | |
| Ebit Margin | 11.4% | 12.6% | 10.9% | 11.6% | 11.3% | |
| Ebitda Margin | 22.7% | 23.9% | 22.7% | 23.4% | 23.0% | |
| Operating Profit Margin | 11.8% | 11.9% | 10.9% | 12.1% | 11.8% | |
| Pretax Profit Margin | 8.6% | 9.9% | 8.6% | 9.4% | 8.8% | |
| Continuous Operations Profit Margin | 7.7% | 8.4% | 7.9% | 8.7% | 8.4% | |
| Net Profit Margin | 7.7% | 8.4% | 7.7% | 9.4% | 10.9% | |
| Bottom Line Profit Margin | 7.7% | 8.4% | 7.4% | 9.0% | 10.5% | |
| Current Ratio | 1.113 | 1.169 | 1.306 | 1.042 | 1.334 | |
| Quick Ratio | 0.645 | 0.740 | 0.814 | 0.629 | 0.920 | |
| Solvency Ratio | 0.138 | 0.127 | 0.140 | 0.145 | 0.143 | |
| Cash Ratio | 0.102 | 0.207 | 0.213 | 0.148 | 0.361 | |
| Price To Earnings Ratio | 25.197 | 32.235 | 40.895 | 29.541 | 27.246 | |
| Price To Earnings Growth Ratio | -37.039 | 1.761 | -2.526 | -2.065 | 0.180 | |
| Forward Price To Earnings Growth Ratio | -37.039 | 1.761 | -2.526 | -2.065 | 0.180 | |
| Price To Earnings Diluted Ratio | 25.240 | 32.345 | 41.144 | 29.793 | 27.524 | |
| Price To Earnings Diluted Growth Ratio | -49.302 | 1.737 | -2.574 | -2.104 | 0.180 | |
| Price To Book Ratio | 1.661 | 2.121 | 2.256 | 1.975 | 2.304 | |
| Price To Sales Ratio | 1.931 | 2.722 | 3.004 | 2.646 | 2.851 | |
| Price To Free Cash Flow Ratio | 15.796 | 17.878 | 27.511 | 30.077 | 15.967 | |
| Price To Operating Cash Flow Ratio | 12.296 | 14.461 | 19.467 | 18.962 | 11.737 | |
| Debt To Assets Ratio | 0.347 | 0.377 | 0.319 | 0.320 | 0.342 | |
| Debt To Equity Ratio | 0.755 | 0.834 | 0.652 | 0.670 | 0.778 | |
| Debt To Capital Ratio | 0.430 | 0.455 | 0.395 | 0.401 | 0.438 | |
| Long Term Debt To Capital Ratio | 0.410 | 0.418 | 0.370 | 0.361 | 0.424 | |
| Financial Leverage Ratio | 2.179 | 2.213 | 2.046 | 2.094 | 2.276 | |
| Working Capital Turnover Ratio | 17.799 | 11.378 | 16.382 | 14.847 | 7.158 | |
| Operating Cash Flow Ratio | 0.413 | 0.424 | 0.450 | 0.337 | 0.701 | |
| Operating Cash Flow Sales Ratio | 0.157 | 0.188 | 0.154 | 0.140 | 0.243 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.778 | 0.809 | 0.708 | 0.630 | 0.735 | |
| Debt Service Coverage Ratio | 2.187 | 1.591 | 2.497 | 1.581 | 3.930 | |
| Interest Coverage Ratio | 4.206 | 4.540 | 4.670 | 5.734 | 4.797 | |
| Short Term Operating Cash Flow Coverage Ratio | 2.199 | 1.643 | 2.376 | 1.146 | 7.423 | |
| Operating Cash Flow Coverage Ratio | 0.179 | 0.176 | 0.178 | 0.155 | 0.252 | |
| Capital Expenditure Coverage Ratio | 4.513 | 5.239 | 3.420 | 2.706 | 3.775 | |
| Dividend Paid And Capex Coverage Ratio | 1.754 | 2.081 | 1.504 | 1.281 | 2.039 | |
| Dividend Payout Ratio | 0.713 | 0.645 | 0.751 | 0.608 | 0.501 | |
| Enterprise Value Multiple | 12.206 | 15.491 | 16.718 | 14.902 | 16.073 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 45.4% | ▲0.2% | ▲0.9% |
| Ebit Margin | 11.4% | ▼-1.1% | ▼-0.1% |
| Ebitda Margin | 22.7% | ▼-1.2% | ▼-0.4% |
| Operating Profit Margin | 11.8% | ▼-0.1% | ▲0.1% |
| Pretax Profit Margin | 8.6% | ▼-1.3% | ▼-0.5% |
| Continuous Operations Profit Margin | 7.7% | ▼-0.8% | ▼-0.5% |
| Net Profit Margin | 7.7% | ▼-0.8% | ▼-1.1% |
| Bottom Line Profit Margin | 7.7% | ▼-0.8% | ▼-0.9% |
| Current Ratio | 1.113 | ▼-0.056 | ▼-0.080 |
| Quick Ratio | 0.645 | ▼-0.095 | ▼-0.105 |
| Solvency Ratio | 0.138 | ▲0.011 | ▼-0.000 |
| Cash Ratio | 0.102 | ▼-0.105 | ▼-0.104 |
| Price To Earnings Ratio | 25.197 | ▼-7.038 | ▼-5.826 |
| Price To Earnings Growth Ratio | -37.039 | ▼-38.800 | ▼-29.101 |
| Forward Price To Earnings Growth Ratio | -37.039 | ▼-38.800 | ▼-29.101 |
| Price To Earnings Diluted Ratio | 25.240 | ▼-7.105 | ▼-5.969 |
| Price To Earnings Diluted Growth Ratio | -49.302 | ▼-51.039 | ▼-38.890 |
| Price To Book Ratio | 1.661 | ▼-0.460 | ▼-0.402 |
| Price To Sales Ratio | 1.931 | ▼-0.791 | ▼-0.700 |
| Price To Free Cash Flow Ratio | 15.796 | ▼-2.082 | ▼-5.650 |
| Price To Operating Cash Flow Ratio | 12.296 | ▼-2.165 | ▼-3.089 |
| Debt To Assets Ratio | 0.347 | ▼-0.030 | ▲0.006 |
| Debt To Equity Ratio | 0.755 | ▼-0.078 | ▲0.017 |
| Debt To Capital Ratio | 0.430 | ▼-0.024 | ▲0.007 |
| Long Term Debt To Capital Ratio | 0.410 | ▼-0.009 | ▲0.013 |
| Financial Leverage Ratio | 2.179 | ▼-0.034 | ▲0.018 |
| Working Capital Turnover Ratio | 17.799 | ▲6.421 | ▲4.286 |
| Operating Cash Flow Ratio | 0.413 | ▼-0.011 | ▼-0.052 |
| Operating Cash Flow Sales Ratio | 0.157 | ▼-0.031 | ▼-0.019 |
| Free Cash Flow Operating Cash Flow Ratio | 0.778 | ▼-0.030 | ▲0.046 |
| Debt Service Coverage Ratio | 2.187 | ▲0.596 | ▼-0.170 |
| Interest Coverage Ratio | 4.205 | ▼-0.334 | ▼-0.584 |
| Short Term Operating Cash Flow Coverage Ratio | 2.199 | ▲0.556 | ▼-0.759 |
| Operating Cash Flow Coverage Ratio | 0.179 | ▲0.003 | ▼-0.009 |
| Capital Expenditure Coverage Ratio | 4.513 | ▼-0.726 | ▲0.583 |
| Dividend Paid And Capex Coverage Ratio | 1.754 | ▼-0.328 | ▲0.022 |
| Dividend Payout Ratio | 0.713 | ▲0.068 | ▲0.069 |
| Enterprise Value Multiple | 12.206 | ▼-3.285 | ▼-2.872 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $42.17B | $54.92B | $58.19B | $49.93B | $54.54B | |
| Enterprise value | $60.50B | $74.65B | $73.59B | $65.72B | $70.57B | |
| EV / Sales | 2.77x | 3.70x | 3.80x | 3.48x | 3.69x | |
| EV / Op. cash flow | 17.64x | 19.66x | 24.62x | 24.96x | 15.19x | |
| EV / Free cash flow | 22.66x | 24.30x | 34.80x | 39.59x | 20.66x | |
| EV / EBITDA | 12.21x | 15.49x | 16.72x | 14.90x | 16.07x | |
| Net debt / EBITDA | 3.70x | 4.09x | 3.50x | 3.58x | 3.65x | |
| Current ratio | 1.11x | 1.17x | 1.31x | 1.04x | 1.33x | |
| Income quality | 2.04x | 2.23x | 1.95x | 1.48x | 2.22x | |
| Graham number | $108 | $109 | $103 | $112 | $115 | |
| Graham net-net | -$87 | -$86 | -$77 | -$82 | -$85 | |
| Tax burden | 89.2% | 85.0% | 89.3% | 99.8% | 123.6% | |
| Interest burden | 75.4% | 79.2% | 78.6% | 81.8% | 78.3% | |
| Working capital | $942.0M | $1.51B | $2.04B | $330.0M | $2.21B | |
| Invested capital | $43.96B | $45.72B | $44.06B | $43.27B | $44.88B | |
| Return on assets | 3.0% | 3.0% | 2.8% | 3.4% | 3.9% | |
| Operating ROA | 4.6% | 4.4% | 4.0% | 4.3% | 4.2% | |
| Return on tangible assets | 8.7% | 8.6% | 8.6% | 11.1% | 12.2% | |
| Return on equity | 6.6% | 6.6% | 5.8% | 7.0% | 8.8% | |
| Return on invested capital | 4.7% | 4.0% | 4.1% | 4.4% | 4.5% | |
| Return on capital employed | 5.5% | 5.0% | 4.6% | 5.1% | 4.8% | |
| Earnings yield | 4.0% | 3.1% | 2.6% | 3.6% | 3.8% | |
| Free cash flow yield | 6.3% | 5.6% | 3.6% | 3.3% | 6.3% | |
| Capex / Op. cash flow | 22.2% | 19.1% | 29.2% | 37.0% | 26.5% | |
| Capex / Depreciation | 30.9% | 31.7% | 38.2% | 43.7% | 54.2% | |
| Capex / Sales | 3.5% | 3.6% | 4.5% | 5.2% | 6.4% | |
| SG&A / Sales | 24.2% | 24.1% | 24.4% | 25.0% | 24.7% | |
| R&D / Sales | 5.8% | 5.9% | 6.4% | 6.7% | 6.7% | |
| Stock comp / Sales | 1.2% | 1.2% | 1.3% | 1.2% | 1.2% | |
| Intangibles / Total assets | 65.1% | 65.3% | 67.2% | 69.8% | 68.1% | |
| Days sales outstanding | 50d | 55d | 48d | 42d | 45d | |
| Days payables outstanding | 60d | 63d | 53d | 60d | 60d | |
| Operating cycle | 169d | 182d | 154d | 156d | 140d | |
| Cash conversion cycle | 109d | 119d | 101d | 96d | 80d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-23.2%EV / Sales ▼-25.1%EV / EBITDA ▼-21.2%EV / Op. cash flow ▼-2.016Earnings yield ▲+0.009Graham number ▼-0.735
Profitability
Return on equity +0.000Return on assets ▲+0.001Return on invested capital ▲+0.007Return on capital employed ▲+0.005Operating ROA ▲+0.002Income quality ▼-0.183Tax burden ▲+0.041
Efficiency
Days sales outstanding ▼-4.825Days payables outstanding ▼-2.140Operating cycle ▼-12.443Cash conversion cycle ▼-10.303Capex / Sales ▼-0.001R&D / Sales ▼-0.001
Balance-sheet strength
Current ratio ▼-0.056Net debt / EBITDA ▼-0.396Working capital ▼-570000000.000Invested capital ▼-1759000000.000Intangibles / Total assets ▼-0.002
Change over 5 years
Valuation
Market cap ▼-22.7%EV / Sales ▼-24.9%EV / EBITDA ▼-24.1%EV / Op. cash flow ▲+2.453Earnings yield ▲+0.001Graham number ▼-7.375
Profitability
Return on equity ▼-0.022Return on assets ▼-0.008Return on invested capital ▲+0.003Return on capital employed ▲+0.007Operating ROA ▲+0.004Income quality ▼-0.177Tax burden ▼-0.345
Efficiency
Days sales outstanding ▲+5.204Days payables outstanding ▲+0.020Operating cycle ▲+29.139Cash conversion cycle ▲+29.119Capex / Sales ▼-0.030R&D / Sales ▼-0.009
Balance-sheet strength
Current ratio ▼-0.221Net debt / EBITDA ▲+0.047Working capital ▼-1270000000.000Invested capital ▼-929000000.000Intangibles / Total assets ▼-0.030
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-05-21 | Thomas H. Kean | Sale | $1,001 - $15,000 |
| 2026-03-17 | Kevin Hern | Sale | $15,001 - $50,000 |
| 2025-09-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-06-24 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-06-17 | Lisa McClain | Purchase | $1,001 - $15,000 |
| 2025-05-15 | Rob Bresnahan | Purchase | $1,001 - $15,000 |
| 2025-05-13 | Thomas H. Kean | Purchase | $1,001 - $15,000 |
| 2025-04-08 | Rob Bresnahan | Sale | $1,001 - $15,000 |
| 2025-03-05 | Jefferson Shreve | Sale | $15,001 - $50,000 |
| 2024-09-11 | William R. Keating | Sale | $1,001 - $15,000 |
| 2024-09-09 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-09-04 | John James | Sale (Full) | $1,001 - $15,000 |
| 2024-05-24 | Thomas H. Kean | Purchase | $1,001 - $15,000 |
| 2024-03-25 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-03-21 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-02-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-02-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2024-01-11 | Thomas H. Kean | Purchase | $1,001 - $15,000 |
| 2024-01-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2024-01-03 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-11-10 | John James | Purchase | $1,001 - $15,000 |
| 2023-10-31 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2023-10-24 | Greg Stanton | Sale | $1,001 - $15,000 |
| 2023-10-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-09-26 | Greg Stanton | Purchase | $1,001 - $15,000 |
| 2023-06-29 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2023-05-25 | Zoe Lofgren | Sale | $1,001 - $15,000 |
| 2023-05-23 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2023-04-20 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-04-17 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-02-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-12-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-11-03 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2022-10-20 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-10-20 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-09-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-09-09 | Zoe Lofgren | Purchase | $1,001 - $15,000 |
| 2022-09-06 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-08-01 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-06-16 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2022-05-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-05-05 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2022-04-22 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2022-02-17 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2022-01-21 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2021-10-28 | Kim Schrier | Sale (Full) | $1,001 - $15,000 |
| 2021-06-22 | John Curtis | Sale (Full) | $1,001 - $15,000 |
| 2021-05-12 | Marjorie Taylor Greene | Purchase | $1,001 - $15,000 |
| 2021-04-09 | Sara Jacobs | Sale (Full) | $15,001 - $50,000 |
| 2020-11-30 | Michael McCaul | Sale (Full) | $50,001 - $100,000 |
| 2020-11-30 | Michael McCaul | Sale (Full) | $50,001 - $100,000 |
| 2020-11-27 | Michael McCaul | Sale (Full) | $50,001 - $100,000 |
| 2020-11-27 | Michael McCaul | Sale (Full) | $50,001 - $100,000 |
| 2020-11-19 | Kevin Hern | Sale (Full) | $1,001 - $15,000 |
| 2020-09-22 | Francis Rooney | Purchase | $1,001 - $15,000 |
| 2020-09-10 | Francis Rooney | Purchase | $1,001 - $15,000 |
| 2020-08-26 | Francis Rooney | Purchase | $1,001 - $15,000 |
| 2020-08-25 | David B. McKinley | Sale (Full) | $15,001 - $50,000 |
| 2020-08-20 | David B. McKinley | Sale (Full) | $1,001 - $15,000 |
| 2020-05-22 | Robert J. Wittman | Sale (Full) | $1,001 - $15,000 |
| 2020-05-19 | K. Michael Conaway | Sale (Full) | $15,001 - $50,000 |
| 2020-04-30 | David B. McKinley | Purchase | $1,001 - $15,000 |
| 2020-04-30 | David B. McKinley | Purchase | $1,001 - $15,000 |
| 2020-04-09 | Kevin Hern | Purchase | $1,001 - $15,000 |
| 2020-03-27 | John Curtis | Purchase | $1,001 - $15,000 |
| 2020-02-20 | Mikie Sherrill | Sale (Full) | $1,001 - $15,000 |
| 2019-10-30 | Mikie Sherrill | Sale (Full) | $50,001 - $100,000 |
| 2019-07-09 | Elizabeth Fletcher | Sale (Full) | $1,001 - $15,000 |
| 2019-06-12 | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 2019-04-18 | K. Michael Conaway | Purchase | $1,001 - $15,000 |
| 2019-02-26 | Elizabeth Fletcher | Sale (Full) | $1,001 - $15,000 |
| 2019-02-05 | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 2018-11-21 | K. Michael Conaway | Purchase | $1,001 - $15,000 |
Recent news
- 2026-08-17 BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire FRANKLIN LAKES, N.J., Aug. 17, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Gary Sorsher has been named executive vice president and chief quality officer, effective September 8.
- 2026-08-13 Buy, Sell, or Hold These 4 Dividend Kings After Earnings: BDX, ED, EMR, PH Four Dividend Kings - Becton, Dickinson and Company (BDX), Consolidated Edison (ED), Emerson Electric (EMR), and Parker-Hannifin (PH) - reported earnings last week.
- 2026-08-13 Becton Dickinson: An Earnings Beat Again As Diverse Clinical Portfolio Keeps On Growing Becton Dickinson gets its prior buy rating reaffirmed again, agreeing with the latest Wall St consensus. Key strengths are its diverse and growing clinical portfolio expected to drive further upside, while a favorable Fitch rating lowers balance sheet risk. Market performance vs the S&P 500 is improving again.
- 2026-08-12 BDX DCF Analysis: Intrinsic Value $141 vs Price $181 On August 12, 2026, we delve into the DCF analysis for Becton Dickinson and Co (BDX), a company that has shown notable price performance recently, with a year-to-
- 2026-08-12 BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial Enrollment completed in the first large-scale randomized study evaluating Phasix™ Mesh for incisional hernia prevention, a significant unmet need following abdominal surgery FRANKLIN LAKES, N.J., Aug. 12, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a significant milestone in its advanced tissue regeneration strategy and expansion efforts with successful completion of enrollment in the PREVENT clinical trial evaluating Phasix™ Mesh for the prevention of incisional hernias.
- 2026-08-11 First Eagle Investment Buys Becton Dickinson & Co (BDX) -- Shares Look 6% Undervalued on GF Value On June 30, 2026, First Eagle Investment (Trades, Portfolio) executed a significant add transaction for Becton Dickinson and Co (NYSE: BDX), increasing the firm''s
- 2026-08-10 We Said These 4 Dividend Aristocrats Could Soar. Here''s How They Did, Plus 3 New Picks. About a year ago, 24/7 Wall St. flagged four overlooked Dividend Aristocrats as stealth growth plays, arguing that boring income names carried real upside if the market ever noticed.
- 2026-08-07 Becton Dickinson & Co (BDX) (Q3 2026) Earnings Call Highlights: Strong Revenue Growth and Raised Guidance Amid Tariff Pressures Revenue: $5 billion, up 4.4% on an FX-neutral basis.Adjusted Operating Margin: 24.9%, down 130 basis points versus the prior year.Adjusted Gross Margin: 54.3%,
- 2026-08-07 Becton, Dickinson and Company Q3 Earnings Call Highlights Becton, Dickinson and Company NYSE: BDX reported third-quarter fiscal 2026 revenue of $5 billion, up 4.4% on an FX-neutral basis, as growth across its key platforms and operational productivity helped results exceed the company''s expectations.
- 2026-08-06 BD Stock Up in Pre-Market Post Q3 Earnings & Revenue Beat, Margins Down BDX tops third-quarter fiscal 2026 earnings and revenue estimates as broad segment growth offset pressure on gross and operating margins.